ArticleCardiovascular diabetology. Endocrinology reports2026
Beyond blood pressure: carotid intima-media thickness uncovers subclinical atherosclerosis in normotensive adults with type 2 diabetes in Sub-Saharan Africa.
Article in Cardiovascular diabetology. Endocrinology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundDiabetes mellitus is strongly linked to a heightened risk of cardiovascular disease. Carotid intima-media thickness (CIMT) is increasingly utilized as a surrogate marker of atherosclerosis and cardiovascular disease risk. This study aimed to evaluate CIMT through high-resolution ultrasonography in adults with Type 2 diabetes and assess its potential association with selected clinical factors within a native Black African population. METHODOLOGY: An analytical cross-sectional study was conducted between November 2022 and February 2023 at the Diabetic Clinic of Mulago National Referral Hospital, Kampala, Uganda. One hundred normotensive adults with Type 2 diabetes were enrolled by consecutive sampling. CIMT was measured bilaterally at the common carotid artery using high-resolution Doppler ultrasonography. Clinical variables collected included age, sex, body mass index (BMI), glycated haemoglobin (HbA1c), fasting lipid profile, and diabetes duration. Multivariable Poisson regression with robust standard errors was used to estimate adjusted prevalence ratios (aPR).
resultsThe mean age was 52.4 years (SD 11.2) and 62% of participants were female. The median diabetes duration was 10.0 years and the median HbA1c was 9.9% (IQR 7.8-10.9). Abnormal CIMT (> 0.9 mm) was found in 61% (61/100) of participants. On multivariable analysis, independent predictors of abnormal CIMT included age > 45 years (aPR 1.17, 95% CI 1.08-1.28), high LDL cholesterol (aPR 1.20, 95% CI 1.07-1.36), poor or very poor glycemic control (HbA1c > 8%; aPR 1.16, 95% CI 1.01-1.32), and diabetes treatment duration > 9 years (aPR 1.11, 95% CI 1.01-1.21).
conclusionsAmong normotensive Ugandan adults with Type 2 diabetes, 61% had increased CIMT. Independent predictors were older age, poor glycemic control, high LDL cholesterol, and longer disease duration. CIMT assessment offers a simple, non-invasive adjunct for identifying subclinical atherosclerosis and may improve cardiovascular risk stratification in this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.